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Abstract
Retiform hemangioendothelioma (RH) is a rare low-grade variant of angiosarcoma mostly reported on dermis or
subcutaneously. A 30-year-old woman suffering from dry cough, dyspnea and pleural effusion has been described.
Distinctive symptoms and lesions on high resolution computed tomography (HRCT) scan and common histological,
immunological feature are discussed. Diagnosis was made by thoracoscopy as RH.
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Background
RH is known as a rare kind of low-grade malignant angio-
sarcoma with high rate of local recurrence and low poten-
tial of metastasis which is a sparsely distributed disease
counting 35 cases (Table 1) whereas none of them is re-
lated to pleura or lung [1]. Given the lacking information
of pleural RH, its clinical manifestation, HRCT presenta-
tion and thoracoscopic appearance of a female patient are
presented. The definitive diagnosis was made due to
pathological observation and immunochemical staining.
The prognosis is unpredictable since the tumor can affect
multiple organs [2]. Unfortunately, consensus has not been
reached on if there is effective treatment to this tumor.
Case presentation
Clinical history and radiology
A 30-year-old female patient was admitted to pulmonary
department because of dyspnea and dry cough denying
chest pain, hemoptysis, fever, weight loss or other systemic
symptoms. Her symptoms were stable and had not been
given any medication prior to admission. Her chest X-ray
by local hospital showed pleural effusion on the right side.
She received modified radical mastectomy in 2006 remov-
ing a breast mass on her right chest. The biopsy confirmed
a diagnosis of poorly-differentiated invasive ductal carcin-
oma with axillary lymph nodes metastasis therefore the
patient received adjuvant chemotherapy and radiotherapy.
Her father died of liver cancer. The rest of her personal his-
tory, social history and the review of systems were unre-
markable. Decreased vocal fremitus and dullness of
percussion on her right thorax were detected in physical
examination. No enlarged superficial lymph nodes were
palpated and laboratory tests revealed normal level of
carcino-embryonic antigen (CEA). Her ultrasonic examin-
ation of abdomen and pelvis cavity alarmed no metastatic
signs. The patient’s HRCT results showed merely pleural
effusion on the right side (Fig. 1). No residual mass, en-
larged lymph nodes of hilar or lesion on pleura were ob-
served. Laboratory tests of her pleural effusion samples
contained erythrocytes and leukocytes and it was exudates.
Furthermore, cytological examination reported large
amount of lymphocytes without atypical or carcinomatous
cells. Scattered greyish variously sized nodes were discov-
ered on costal pleura in thoracoscopy. The lesion presented
themselves as exophytic masses surrounded by indistinctive
borders with a tendency to fuse together. Pulmonary and
diaphragmatic pleura were free from infiltration. Recheck-
ing of chest X-ray complied with her former HRCT scan.
Histology and immunohistochemistry
Histological and immunological examination of biopsy
specimen pictured disarranged, jagged, blood vessels of
thin walls and slit-like fissures were prevailing. At higher
magnification the vessels’ walls were lined with highly
nuclei/cytoplasm ratioed endothelial cells with minimal
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cytological atypia and mitosis. Atypical cells protruding
into lumina mimicking “hobnail” appearance or endo-
thelial papillae was absent as well as their invasion into
adjacent tissues. Infiltration of lymphocytes was also rare
(Fig. 2). Combined with immunohistochemical staining
positive for CD31, CD34, D2-40 (Fig. 3) and negative for
CrebB-2, GCDFP-15, CEA, CA15-3, S-100, Ki-67 and
myogenin, which confirmed the diagnosis and ruled out
the possibility of breast cancer and other diagnosis, a
diagnosis of RH was established.
Results
According to our knowledge and clinical experience,
endostatin was recommended for treatment. The patient
revisited 6 months later with relieved symptoms when
her HRCT showed diminished and encapsulated pleural
effusion after receiving symptomatic treatment and
passed away at home in 2013.
Discussion
Hemangioendothelioma (HE), an intermediate lesion be-
tween hemangioma and angiosarcoma, has been incipiently
delineated as a kind of vascular tumor highlighted by its
marginal biological features [3]. It generally appears on skin
or in soft tissues and extensively includes HE of epithelioid,
kaposiform, retiform, composite and pseudomyogenic (also
known as epithelioid sarcoma-like HE) subgroups and pap-
illary intralymphatic angioendothelioma (also known as
Dabska tumor). Malignancy of pseudomyogenic HE has re-
cently been re-recognized [4]. Definitive diagnosis of varied
types of this tumor is based on histopathlological morph-
ology and immunohistochemical markers [5]. HE on
Table 1 Summary of clinical features of reported RH cases
Author (N) Age/Gender Site Immunochemistry Metastasis Treatment Survival





Fukunaga (1) 75/F Lower limb CD31, vimentin, UEA-1 (all),
CD34, f-VIII (part)
0/1 ND ND
Duke (1) 30/F Upper limb, trunk CD31, f-VIII 0/1 Excision >10 years
Samz-Trelles (1) 11/M Lower limb Vimentin, f-VIII 0/1 Excision >4 years
Schommer (1) 73/F Trunk CD31,UEA-1, f-VIII 0/1 Excision, RT, IT >1 year
Darouti (1) 32/F Lower limb f-VIII ND ND >1.5 years
Tan (1) 19/F Lower limb ND 0/1 Excision >14 months
Ioannidon (1) 55/F Upper limb CD31 0/1 Excision >4 years




Bhutoria (1) 35/F Trunk ND Lymph node Excision ND
Emberger (1) 17/M Trunk CD31,D2-40 0/1 Excision >3 years
Zhang (1) 61/F Head CD34, f-VIII, vimentin 0/1 Excision(twice) 6 months
Aydıngöz (1) 60/F Lower limb ND 0/1 Excision >2 years
Hirsh (1) 44/M Trunk CD31 0/1 Resection,chemoradiation >36 months
Keiler (1) 11/F Upper limb ND 0/1 Excision ND
O’Duffy (1) 18/M Head ND Lymph node Excision, RT ND
Albertini(1) 6/F Trunk D2-40 Lung Excision 6 months
Choi (1) 20/M Upper limb f-VIII ND Excision ND
Couceiro (1) 50/F Upper limb ND ND Excision >4 years
Mota (1) 26/F Trunk CD31, D2-40 ND Excision ND
Al-Faky 9/F Head CD31, CD34, D2-40, f-VIII ND Excision >6 years
ND not documented, M male, F female, UEA-1 ulex europaeus agglutinin 1, f-VIII factor VIII-related antigen, RT radiotherapy, IT immunotherapy
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pleura are limitedly documented as majority of them
have been confirmed as epithelioid hemangioendothe-
lioma (EH). Though EH favorably links to lung and
pleura according to published cases, there has never
been a description of its counterpart-retiform heman-
gioendothelioma on pleura.
Retiform hemangioendothelioma is a low-grade variant
angiosarcoma which has been first introduced by Calonje
in 1994 [6]. Hyperchromatic nuclei without mitosis sug-
gests its intermediate characters [7] and indicates discrep-
ant prognosis.
RH demonstrates a predilection for female adults [6].
The majority of RH cases have been described as lesions
on trunk or limbs [8] whereas penis and scalp were oc-
casionally involved [9]. Features of RH’s lesion vary
among individual patients expressing as masses, which is
hyperhidrotic, or erosion [8, 10, 11]. Exophytic pattern
seems to be more prevailing [8]. All the lesions in this
patient were surrounded by “poor circumscription” as a
presentation of its histological character.
Histological diagnosis lays the foundation of clinical
diagnosis also plays the key role in differentiating RH
from angiosarcoma and other subtypes of hemangioen-
dothelioma. RH comprises of blood vessels ”weaving a
net” by infiltrating into bundles of collagen. Endothelial
cells fashion intraluminal papillea with scarce cytoplasm
[8, 12]. However, pathological sample in this case for
histological examination may accidentally be a single com-
ponent of “composite hemangioendothelioma” which con-
tains retiform HE, epithelioid HE, angiosarcoma, spindle
cell hemangioma, lymphangioma, arteriovenous malfor-
mation [13] or part of these. This assumption is drawn
from the fact that excision of gross sample has not be per-
formed taking the fact that EH tends to form in lung into
consideration [14].
Histochemical markers of RH include CD31, D2-40,
CD34, factor VIII-related antigen [15, 16] among which
CD34, factor VIII-related antigen have been consistently
reported. CD34 and CD31 symbolize endothelial lineage
and D2-40 expresses on other kinds of lymphatic heman-
gioendothelioma or hemangioma [17, 18]. Controversy,
nevertheless, has been aroused by Amy Parson's
Fig. 2 Hematoxylin and eosin staining of the patient’s sample.
Hematoxylin and eosin staining presented atypical cells forming
disarranged and abnormal lumina. Some of the “vessels” were
complete and contained erythrocytes and main part of the tumor
consisted of zigzag slits. No atypia or mitosis of nuclei showed in
the cells meanwhile cytoplasm was insufficient
Fig. 3 Immunohistochemical staining of the patient’s sample.
Immunohistochemical staining for D2-40 expression was positive
Fig. 1 HRCT scan of the patient before thoracoscopy. Small amount of unilateral pleural effusion was detected on the right side of the patient.
None visible pleural nodes were reported. (Opacity showed in the patient’s right lung which has been proved to be bacterial infection because it
disappeared after treatment of antibiotics)
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demonstration of 3 negative cases of D2-40 in 4 RH pa-
tients [19].
Though histological and clinical features permits dif-
ferential diagnosis between RH and other vascular tu-
mors [20], it shares a number of similarities with hobnail
hemangioma which has been considered as it benign
counterpart. However, hobnail hemangioma features
shortage of papillae protruding into lumina and re-
stricted location [21] while prominent lymphatic infiltra-
tion and extensive lesion (dermis and subcutis) are
widely applied to make the RH diagnosis [22]. Moreover,
definitive diagnosis of a papillary lymphatic angioen-
dothelioma with partial “netlike” camouflage and D2-40
positivity was in arguement [21].
The etiology of RH remains obscure. Latent relations
between malignant medical history and RH should be
elucidated [2, 9]. In this case no evidence supports the
internal link between RH occurence and the past
radiotherapy.
No tumor-related [8] deaths in RHs are observed
under the circumstance of low metastasis. However, a
locally invasive RH in China and a metastatic RH in a
six-year-old girl turned out to be lethal [23]. Although
adjuvant immunotherapy and radiotherapy have been
proved to be effective in several cases, none agreed
tumor-responding treatments are recommended unless a
complete surgical excision is performed [24–27].
Amanda and her colleagues, however, proposed specific
appearance on dermoscopy as practical assistance to
diagnosis and therapy [28].
Conclusions
In summary, a case of RH situating on pleura has been
depicted which exhibited peculiar pathological, immuno-
logical features and lesions. It has been reported as in-
trathoracic nodules predisposing a patient to unilateral
pleural effusion. However discussion has been placed on
the causes and treatment of RH. It implies that RH on
location other than skin or subcutis may lead to corre-
sponding symptoms or even threatened survival.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
RH: Retiform hemangioendothelioma; CEA: Carcino-embryonic antigen;
HRCT: High resolution computed tomography; HE: Hemangioendothelioma;
EH: Epithelioid hemangioendothelioma.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
QL collected the information and drafted the manuscript. RO attended the
patient, arranged the clinical examination. PC participated in the medical
decisions. RZ revised the manuscript. All authors read and approved the
final manuscript.
Authors’ information
Qingqing Liu, Email: lqq.aileen@outlook.com
Ruoyun Ouyang, Email: ruoyun001@126.com
Ping Chen, Email: pingchen0731@sina.com
Rui Zhou, Phone: +86-731-5292100, Email: zhourui2355@sina.com
Acknowledgements
We thank Dr. Xia Wu at Department of Pathology and Dr. Juan Chen
at Department of Radiology in the 2nd Xiangya Hospital for offering
information. We thank Prof. Hong Peng, Prof. Yan Chen at Department of
Respiratory Medicine in the 2nd Xiangya Hospital and Dr. Ye Gan at Yale
University for helping drafting the manuscript. We thank Dr. Bowen Xie from
the Center for Molecular Medicine of Central South University for editing the
pictures. Special gratitude should be shown to Prof. Daiqiang Li at
Department of Pathology in the 2nd Xiangya Hospital and Prof. Jihe Li
at Department of Pathology in the 1st Xiangya Hospital for professional
opinions in making the diagnosis. This study is financially supported by
grants from the National Key Clinical Specialty Construction Projects.
Received: 30 June 2015 Accepted: 17 October 2015
References
1. O’Duffy F, Timon C, Toner M. A rare angiosarcoma: retiform
haemangioendothelioma. J Laryngol Otol. 2012;126(2):200–2.
2. Albertini A-F, Brousse N, Bodemer C, Calonje E, Fraitag S. Retiform
hemangioendothelioma developed on the site of an earlier cystic
lymphangioma in a six-year-old girl. Am J Dermatopathol. 2011;33(7):e84–e7.
3. Weiss SW, Enzinger F. Epithelioid hemangioendothelioma a vascular tumor
often mistaken for a carcinoma. Cancer. 1982;50(5):970–81.
4. Doyle LA. Sarcoma classification: an update based on the 2013 World
Health Organization Classification of Tumors of Soft Tissue and Bone.
Cancer. 2014;120(12):1763–74.
5. Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol.
2013;30(1):29–44.
6. Calonje E, Fletcher C, Wilson-Jones E, Rosai J. Retiform
hemangioendothelioma. A distinctive form of low-grade angiosarcoma
delineated in a series of 15 cases. Am J Surg Pathol. 1994;18(2):115–25.
7. Duke D, Dvorak AM, Harris TJ, Cohen LM. Multiple retiform
hemangioendotheliomas: a low-grade angiosarcoma. Am J Dermatopathol.
1996;18(6):606–10.
8. Tan D, Kraybill W, Cheney RT, Khoury T. Retiform hemangioendothelioma:
a case report and review of the literature. J Cutan Pathol. 2005;32(9):634–7.
9. Ioannidou D, PanayIotides J, Krasagakis K, Stefanidou M, Manios A, Tosca A.
Retiform hemangioendothelioma presenting as bruise‐like plaque in an
adult woman. Int J Dermatol. 2006;45(1):53–5.
10. Schommer M, Herbst RA, Brodersen JP, Kiehl P, Katenkamp D, Kapp A, et al.
Retiform hemangioendothelioma: another tumor associated with human
herpesvirus type 8? J Am Acad Dermatol. 2000;42(2):290–2.
11. Aydıngöz İE, Mansur AT, Celasun B. Correspondence: Retiform
hemangioendothelioma presenting as a hyperhidrotic tumor. Int J
Dermatol. 2010;49(9):1076–7.
12. Darouti ME, Marzouk SA, Sobhi RM, Bassiouni DA. Retiform
hemangioendothelioma. Int J Dermatol. 2000;39(5):365–8.
13. Fukunaga M, Suzuki K, Saegusa N, Folpe AL. Composite
hemangioendothelioma: report of 5 cases including one with associated
Maffucci syndrome. Am J Surg Pathol. 2007;31(10):1567–72.
14. Cronin P, Arenberg D. Pulmonary Epithelioid Hemangioendothelioma: an
Unusual Case and a Review of the Literature. CHEST J. 2004;125(2):789–93.
15. Bhutoria B, Konar A, Chakrabarti S, Das S. Retiform hemangioendothelioma
with lymph node metastasis: a rare entity. Indian J Dermatol Venereol
Leprol. 2009;75(1):60–2.
16. Emberger M, Laimer M, Steiner H, Zelger B. Retiform hemangioendothelioma:
presentation of a case expressing D2‐40. J Cutan Pathol. 2009;36(9):987–90.
Liu et al. Diagnostic Pathology  (2015) 10:194 Page 4 of 5
17. Miettinen M, Wang Z-F. Prox1 transcription factor as a marker for vascular
tumors–evaluation of 314 vascular endothelial and 1086 nonvascular
tumors. Am J Surg Pathol. 2012;36(3):351.
18. Fukunaga M. Expression of D2‐40 in lymphatic endothelium of normal
tissues and in vascular tumours. Histopathology. 2005;46(4):396–402.
19. Parsons A, Sheehan DJ, Sangueza OP. Retiform hemangioendotheliomas
usually do not express D2-40 and VEGFR-3. Am J Dermatopathol.
2008;30(1):31–3.
20. Fukunaga M, Endo Y, Masui F, Yoshikawa T, Ushigome S, Ishikawa E.
Retiform haemangioendothelioma. Virchows Arch. 1996;428(4-5):301–4.
21. Wachter DL, Agaimy A. A cutaneous vascular neoplasm with hobnail
microscopic morphology and unusual gross features. J Cutan Pathol.
2012;39(4):454–7.
22. Guillou L, Calonje E, Speight P, Rosai J, Fletcher CD. Hobnail hemangioma:
a pseudomalignant vascular lesion with a reappraisal of targetoid
hemosiderotic hemangioma. Am J Surg Pathol. 1999;23(1):97–105.
23. Zhang G, Lu Q, Yin H, Wen H, Su Y, Li D, et al. A case of retiform-
hemangioendothelioma with unusual presentation and aggressive clinical
features. Int J Clin Exp Pathol. 2010;3(5):528.
24. Hirsh AZ, Yan W, Wei L, Wernicke AG, Parashar B. Unresectable retiform
hemangioendothelioma treated with external beam radiation therapy and
chemotherapy: a case report and review of the literature. Sarcoma.
2010;2010:1–3.
25. Choi WK, Lee SH, Oh SA, Kang DH. Retiform hemangioendothelioma on the
finger. Arch Plast Surg. 2012;39(1):80–2.
26. Couceiro J, Sanders S, Manon-Matos Y, Banegas R. Retiform
hemangioendothelioma of the finger: a case report. Hand Surg.
2013;18(03):439–41.
27. Al-Faky Y, Al-Mosallam A, Al-Rikabi A, Al-Sohaibani M. Medial canthus
retiform hemangioendothelioma. Indian J Ophthalmol. 2014;62(4):491.
28. Mota A, Argenziano G, Zalaudek I, Piana S, Longo C, Moscarella E, et al.
Clinical, dermoscopic and histopathologic findings of retiform
hemangioendothelioma. Dermatol Pract Concept. 2013;3(4):11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. Diagnostic Pathology  (2015) 10:194 Page 5 of 5
